login

18-Month mortality and perinatal exposure to zidovudine in West Africa

AIDSPublished 1 April 2001
François Dabis, Narcisse Elenga, Nicolas Méda, Valériane Leroy, Ida Viho, Olivier Manigart
Citations77
SJR quartileQ1
SJR score1.21
SNIP0.90

TL;DR

Peripartum maternal zidovudine exerts a protective effect for at least 8 months and is safe and beneficial to African children born to HIV-1-infected mothers.

Abstract

Mother-to-child transmission reduction by zidovudine is safe and beneficial to African children. The mortality of HIV-1-infected children is high. Peripartum maternal zidovudine exerts a protective effect for at least 8 months.

Keywords

Immunology and MicrobiologyMedicine